New research points to possibility for testing to explore early-stage Alzheimer's disease retrieved 24 June 2024 from https://medicalxpress.com/news/2024-06-possibility-explore-early-stage-alzheimer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Jun 20, 2024 Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Research team develops searchable database for Alzheimer's researchA searchable database is now ready to help study Alzheimer's disease.
Source: medical_xpress - 🏆 101. / 51 Read more »
Research finds causal evidence tying cerebral small-vessel disease to Alzheimer’s, dementiaResearch led by in part by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) finds that the most common cerebral small-vessel disease feature seen in brain magnetic resonance imaging is a primary vascular factor associated with dementia risk.
Source: NewsMedical - 🏆 19. / 71 Read more »
New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trialA recent study in Nature Medicine found that LM11A-31, targeting the p75 neurotrophin receptor, is safe and shows promise in slowing Alzheimer's disease progression. The trial indicated significant biomarker improvements and potential benefits for further clinical investigation.
Source: NewsMedical - 🏆 19. / 71 Read more »
Can Alzheimer's really be reversed, as a new documentary claims?Two people diagnosed with Alzheimer's claim to have conquered the disease through simple lifestyle changes.
Source: medical_xpress - 🏆 101. / 51 Read more »
Few UK people likely to be suitable for new Alzheimer's drugs when they become availableFew people in the UK with early stage Alzheimer's disease are likely to be suitable for the latest drugs that aim to halt progress of the condition, yet many are nevertheless likely to be referred for these treatments, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.
Source: medical_xpress - 🏆 101. / 51 Read more »
Few UK Alzheimer's patients suitable for new disease-modifying drugs, study findsFew people in the UK with early stage Alzheimer's disease are likely to be suitable for the latest drugs which aim to halt progress of the condition, yet many are nevertheless likely to be referred for these treatments, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.
Source: NewsMedical - 🏆 19. / 71 Read more »